Nitroglycerin as Spasmolytic Regimen for RAS Prevention in Radial Center
Status:
Unknown status
Trial end date:
2019-10-01
Target enrollment:
Participant gender:
Summary
The investigators will investigate whether administration of Nitroglycerin (NTG) as
spasmolytic regimen reduces the incidence of moderate to severe radial artery spasm (RAS) in
patients undergoing transradial catheterization in radial center.